LONDON (Reuters) - GlaxoSmithKline's top-selling respiratory drug Advair is set to lose business to Spiriva, marketed by Pfizer and Boehringer Ingelheim, according to analysts at Morgan Stanley. Sign ...
Advair is used to treat asthma and chronic obstructive pulmonary disease. The Association for Accessible Medicines is voicing strong opposition that the proposed U.S.-Mexico-Canada trade agreement ...
October 27, 2006 (Salt Lake City) -- New findings from the landmark Towards a Revolution in COPD Health (TORCH) study show that high-dose inhaled fluticasone propionate 500 mg/salmeterol 50 mg ( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results